New drug trial hopes to tame rare blood cancers
Disease control
Recruiting now
This early-stage study tests a new drug called PRT12396 in about 100 people with two rare blood cancers: polycythemia vera and myelofibrosis. The main goals are to find a safe dose and check for side effects. Researchers will also look for signs that the drug helps control the di…
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Apr 29, 2026 05:31 UTC